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Abstract Phenotypic variation results from variation in
gene expression, which is modulated by genetic and/or epi-
genetic factors. To understand the molecular basis of
human disease, interaction between genetic and epigenetic
factors needs to be taken into account. The asthma-associ-
ated region 17q12-q21 harbors three genes, the zona pellu-
cida binding protein 2 (ZPBP2), gasdermin B (GSDMB)
and ORM1-like 3 (ORMDL3), that show allele-speciWc
diVerences in expression levels in lymphoblastoid cell lines
(LCLs) and CD4+ T cells. Here, we report a molecular
dissection of allele-speciWc transcriptional regulation of the
genes within the chromosomal region 17q12-q21 combin-
ing in vitro transfection, formaldehyde-assisted isolation of
regulatory elements, chromatin immunoprecipitation and
DNA methylation assays in LCLs. We found that a single
nucleotide polymorphism rs4795397 inXuences the activity
of ZPBP2 promoter in vitro in an allele-dependent fashion,
and also leads to nucleosome repositioning on the asthma-
associated allele. However, variable methylation of exon 1
of ZPBP2 masks the strong genetic eVect on ZPBP2 pro-
moter activity in LCLs. In contrast, the ORMDL3 promoter
is fully unmethylated, which allows detection of genetic
eVects on its transcription. We conclude that the cis-regula-
tory eVects on 17q12-q21 gene expression result from inter-
action between several regulatory polymorphisms and
epigenetic factors within the cis-regulatory haplotype
region.
Introduction
Phenotypic variation is largely dependent on variation in
gene expression levels. To identify the genetic determinants
of phenotypic variation (including complex disease) in the
human population, several genome-wide studies of
genetically deWned diVerences in gene expression levels
succeeded to map cis-regulatory polymorphisms for a pro-
portion of genes with variable expression (Dixon et al.
2007; Ge et al. 2009; Goring et al. 2007; Pastinen et al.
2004; Verlaan et al. 2009b; Yan et al. 2002). In a number of
regions, including the chromosomal region 17q12-q21,
genetic cis-eVects act over several neighboring genes (Ge
et al.  2009; Lluis et al. 2011; Verlaan et al. 2009a,  b).
Genome-wide association studies (GWAS) of gene expression
in LCLs (Verlaan et al. 2009a, b) detected allele-speciWc
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diVerences in the expression of three genes: zona pellucida
binding protein 2 (ZPBP2), ORM1-like 3 (S. cerevisiae)
(ORMDL3) and gasdermin B (GSDMB) located in 17q12-q21
(Fig. 1a). This genomic interval is also associated with
predisposition to early onset asthma, Crohn disease, ulcera-
tive colitis and rheumatoid arthritis (Anderson et al. 2011;
Barrett et al. 2008; MoVatt et al. 2007, 2011; Stahl et al.
2010). A cis-regulatory region responsible for the observed
allele-speciWc diVerences in expression in CEPH LCLs has
been mapped to a 160-kb long genomic interval that over-
laps IKAROS family zinc Wnger 3 (Aiolos) (IKZF3),
ZPBP2,  GSDMB and ORMDL3 (Verlaan et al. 2009a)
(Fig. 1a). Two common cis-regulatory haplotypes, the
asthma-associated HapA and the non-asthma associated
HapB (also harboring the risk alleles for Crohn disease,
ulcerative colitis and rheumatoid arthritis) have been delin-
eated (Verlaan et al. 2009a) (Fig. 1a, b). HapA is associated
with higher expression of ORMDL3 and GSDMB and
lower expression of ZPBP2 whereas HapB is associated
with an opposite pattern of gene expression, i.e. lower
expression of ORMDL3 and GSDMB and higher expres-
sion of ZPBP2. Expression of IKZF3 is similar for both
haplotypes (Verlaan et al. 2009a). Elucidation of the regu-
latory mechanism that underlies the eVect of common
polymorphisms on gene regulation is essential for the
understanding of pathogenesis of asthma and other auto-
immune diseases; therefore a search for functional cis-
regulatory polymorphisms was undertaken. This search
identiWed SNP rs12936231 that modiWes a CTCF-binding
site and inXuences nucleosome occupancy (Verlaan et al.
2009a). Suggestive functional results were found for sev-
eral other SNPs from the candidate regulatory region. To
further elucidate the transcriptional control of this
asthma-associated locus, we focused on the interaction
between genetic and epigenetic factors in the promoter
regions of the three genes whose expression depends upon
the cis-regulatory haplotype.
Materials and Methods
Cell culture of lymphoblastoid cell lines
HapMap LCLs were purchased from the Coriell Cell
Repositories (Camden, NJ) and grown in T75 Xasks in 1£
RPMI 1640 Media (Invitrogen, Carlsbad, CA) (with 2 mM
L-glutamine, 15% fetal bovine serum and 1% penicillin/
streptomycin) at 37°C with 5% CO2. For formaldehyde-
assisted isolation of regulatory elements (FAIRE) and chro-
matin immunoprecipitation (ChIP) assays, LCLs were grown
to 90% conXuence. Two independent cultures of cells
were used for the FAIRE assay (input and FAIRE-treated
cells).
Transient transfection assays
To test for allelic activity, haplotype-speciWc constructs were
subcloned into a pGL3 vector containing a WreXy luciferase
reporter gene either without a promoter or with an SV40 pro-
moter (Promega, Madison, WI) using a previously published
method (Belanger et al. 2005). All constructs were tested in
Wve diVerent human immortalized cell lines: cervical cancer
(HeLa), choriocarcinoma (Jeg3), hepatocellular liver carci-
noma (HepG2), osteosarcoma (MG-63) and CD4+ T-cell
lymphoblast-like (Jurkat). These cell lines were transfected
using lipofectamine™ 2000 according to the manufacturer’s
protocol (Invitrogen, Carlsbad, CA). To control for transfec-
tion eYciency, the measurement of the WreXy luciferase was
normalized to the measurement of the Renilla luciferase.
Experiments were performed in quadruplicate, the activities
of the two luciferases were measured 24 h after transfection
and allelic haplotypes for each SNP were compared. Statisti-
cal signiWcance (P value) was determined using an unpaired
Student’s t test.
Formaldehyde-assisted isolation of regulatory elements 
(FAIRE) assays
The FAIRE procedure was performed as described (Giresi
et al. 2007) with some modiWcations (Verlaan et al. 2009a).
To test for FAIRE enrichment of speciWc SNP regions,
200–400 ng of DNA was ampliWed by PCR. For SNP
regions that showed FAIRE enrichment, normalized Sanger
sequencing was done. FAIRE-treated DNA samples were
compared to the input DNA samples and normalized allelic
ratios were calculated. The primers used for FAIRE analy-
sis are listed in supplementary Table 2S.
Chromatin immunoprecipitation (ChIP) assays
ChIP assays were performed as described in (Verlaan et al.
2009a). The following antibodies were used for ChIP assays:
anti-histone H3K9Ac (06-942), anti-histone H3K27me3
(07-449); anti-C/EBP alpha (04-1104), anti-RNA Pol II
(17-672) and anti-CTCF (07-729) (Millipore, Temecula,
CA); anti-NFB p65 (C-20), anti-YY1 (H-10) and anti-
EP300 (C-20) (Santa Cruz Biotechnology, Inc.). Genomic
regions known to be enriched for these proteins were used as
positive controls [supplementary Table 2S and (Verlaan
et al. 2009a)]. Promoter regions of the tumor necrosis
factor receptor superfamily, member 1A (TNFRSF1A) and
intercellular adhesion molecule 1 (ICAM1) genes that were
used as positive controls for C/EBP alpha did not show
enrichment, possibly due to antibody speciWcity. Primers
used for quantitative PCR analysis or Sanger sequencing
following ChIP assays are listed in the supplementary
Table 2S.Hum Genet (2012) 131:1161–1171 1163
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Sodium bisulWte sequencing methylation analysis
To establish the methylation patterns of regulatory
regions, 0.5–2 g of DNA was treated with sodium bisul-
Wte as previously described (Clark et al. 1994) with modi-
Wcations (Saferali et al. 2010). Assays were designed for
each of the regions of interest. Nested PCR was per-
formed for each of the loci. PCR products were puriWed
using the MinElute gel extraction kit (Qiagen, Hilden,
Germany) and cloned using the TOPO TA cloning kit
(Invitrogen, Carlsbad, CA). The sequencing was done by
the sequencing platform of the McGill University and
Genome Quebec Innovation Centre. On average, 20
clones per sample were sequenced. Characteristics of
regions, primers and PCR conditions are summarized in
Supplementary Table 1S.
Fig. 1 Functional analysis of the cis-regulatory region in 17q12-q21.
a Genomic position of the cis-regulatory haplotype (hg18, chr17:
35,179,985-35,339,296) associated with allelic expression of ORMDL3
and GSDMB (Verlaan et al. 2009a). b Positions of the common SNPs
that form the cis-regulatory haplotype. For each SNP, the genotype
associated with the haplotype A and B (HapA and HapB, respectively)
is indicated on the top. HapA harbors the asthma-associated alleles and
HapB harbors the non-asthma associated alleles. c Relative positions
of the regions analyzed for in vitro promoter or enhancer activity.
d Allelic diVerences in ZPBP2 promoter activity in vitro. The ZPBP2
promoter (region 2) that contains the rs4795397-A allele shows stron-
ger promoter activity in vitro. A pGL3Basic plasmid has been used as
negative control. The Y-axis indicates fold increase in transcription.
Statistically signiWcant allelic diVerences are indicated by asterisks;
e allele-speciWc nucleosome occupancy detected by FAIRE at the
rs4795397 region. Chromatograms for the input and FAIRE-enriched
samples are shown. The position of the SNP rs4795397 is indicated by
an arrow1164 Hum Genet (2012) 131:1161–1171
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Results
Allelic diVerences in ZPBP2 and ORMDL3 promoter 
activity
To determine to what extent allelic diVerences in gene
expression levels in the 17q12-q21 region were deWned by
genetic polymorphisms within gene promoters, the activity
of annotated promoter regions of ZPBP2,  GSDMB and
ORMDL3 was tested in in vitro transfection assays in Wve
diVerent cell types (Table 1; Fig. 1c). The annotated
GSDMB promoter region did not show signiWcant promoter
activity in any of the cell types tested (region 4, Table 1).
Two putative ORMDL3 promoter regions were tested. The
promoter region for the major ORMDL3 isoform showed
high promoter activity in all tested cell lines with no allelic
eVect (region 7, Table 1), whereas the putative promoter
region for the minor isoform of ORMDL3 (region 6) that
included SNP rs12603332 (C/T) showed promoter activity
in MG63 cells with a strong allelic eVect. The construct that
carried the haplotype HapA-associated rs12603332-C allele
had higher promoter activity (P < 0.01, Student’s t test)
(Table 1). However, exome sequencing data suggest that
this promoter is not active in LCLs (Kwan et al. 2009).
The construct including both promoters maintained high
promoter activity; however, the allelic eVect was lost
(Table 1).
In the ZPBP2 promoter region, the construct that carried
the HapA-associated rs4795397-A allele in HeLa, Jeg3,
HepG2 and Jurkat cells showed higher promoter activity
(P <0 . 0 1 ,  S t u d e n t ’ s  t test) (Fig. 1d and region 2; Table 1).
A partially overlapping construct that contained the tran-
scriptional start site, exons 1 and 2 of ZPBP2 was active
only in JEG3 cells and showed a signiWcant allelic eVect
(P < 0.05, Student’s t test) (region 3, Table 1).
In conclusion, the asthma-associated HapA haplotype
variants of the ZPBP2 promoter region and the putative
promoter for the minor ORMDL3 isoform had higher in
vitro promoter activity compared to the variants associated
with the HapB haplotype.
Allele-speciWc regulatory elements
Cis-regulatory allelic eVects may arise from allele-speciWc
diVerences in transcription factor binding and enhancer
activity (Agueda et al. 2011; Bickel et al. 2011; Colombo
et al. 2011; Harmon et al. 2010; Mertens et al. 2010). Tran-
scription factor binding to a regulatory DNA element usu-
ally results in repositioning of nucleosomes. Allelic eVects
of putative regulatory SNPs on nucleosome positioning
were explored using the FAIRE assay that identiWes DNA
regions with reduced nucleosome occupancy, i.e. regions
potentially associated with transcription factors (Giresi
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et al. 2007). Two of the 22 tested SNP regions, rs12936231
and rs4795397, showed both an overall FAIRE enrichment
and allelic diVerences in nucleosome occupancy (Verlaan
et al. 2009a). The eVect of SNP rs12936231 on nucleosome
occupancy and CTCF-binding has been described in detail
elsewhere (Verlaan et al. 2009a). The SNP rs4795397
residing in the proximal promoter region of ZPBP2 also
inXuenced FAIRE enrichment in Wve of six heterozygous
LCLs tested. The rs4795397 A-allele had about twofold
higher FAIRE enrichment than the rs4795397-G allele
(Fig. 1e). The A-allele is part of the asthma-associated hap-
lotype HapA and is associated with lower expression level
of ZPBP2 in CEU LCLs. However, it shows higher pro-
moter activity in vitro (Fig. 1d). Hence, overall our data
indicate that the allele that confers higher promoter activity
in in vitro gene reporter assays and is associated with
reduced nucleosome occupancy, i.e. with transcription fac-
tors in vivo, surprisingly, is the same allele that is associ-
ated with lower expression levels of the ZPBP2 gene.
The Encode ChIP-sequencing results show enrichment
of at least twelve transcription factors within the rs4795397
region (Myers et al. 2011; Raney et al. 2011). These
include the nuclear factor of kappa light polypeptide gene
enhancer in B-cells 1 (NFB) p65 subunit, which is a cen-
tral player in inXammation and immunity, RNA polymerase
II (RNA POL II), and the transcriptional co-activator E1A
binding protein p300 (EP300) (supplementary Fig. 1S).
Analysis of the DNA sequence of the rs4795397 region
(Transcription Element Search System database, http://
www.cbil.upenn.edu/cgi-bin/tess) predicts binding sites for
Yin and Yang 1 (YY1) and the CCAAT/enhancer binding
protein (C/EBP) alpha transcription factors that overlap the
SNP. To determine if SNP rs4795397 inXuences transcrip-
tion factor binding in vivo, enrichment with NFB, EP300,
YY1, C/EBP alpha, RNA POL II and insulator protein
CTCF was tested in LCLs that were homozygous for either
the rs4795397-A or the rs4795397-G allele using ChIP.
The region was enriched with NFB, YY1, EP300 and
RNA POL II (Table 2). High inter-individual variation
between cell lines with respect to transcription factor
enrichment and no statistically signiWcant eVect of the
genotype were observed. We tested the allelic eVect on
NFB alpha and RNA POL II enrichment using ChIP fol-
lowed by Sanger sequencing in two heterozygous cell lines.
No signiWcant allelic diVerences in enrichment were
detected (Table 2). We conclude that NFB, RNA POL II,
YY1 and EP300 bind both alleles in the rs4795397 region.
The rs4795397 region was also highly enriched for the
active histone mark H3Ac, and showed low enrichment for
the inactive histone mark H3K27me3 that were also inde-
pendent from genotype (Table 2). C/EBP alpha ChIP
results were not conclusive as enrichment was not detected
in any of the regions tested including positive controls, per-
haps due to antibody speciWcity.
The transcriptional control of genes within the 17q12-q21
chromosomal region is poorly understood and enhancers that
regulate ORMDL3 and GSDMB expression have not been yet
identiWed. To locate putative enhancers, we searched the
publically available data [UCSC database (Raney et al. 2011;
Myers et al. 2011)] for genomic regions that were enriched
for enhancer-speciWc epigenetic marks e.g. histones
H3K4me1 and H3K27Ac; and/or the transcriptional co-acti-
vator E1A binding protein p300 (EP300) (supplementary
Fig. 1S). These regions were tested for in vitro enhancer
activity (Fig. 1; Table 3 and supplementary Fig. 1S). The
candidate enhancer region overlapping with the 5 region of
the ZPBP2 gene was too large and had to be tested as 3 sepa-
rate overlapping constructs (regions 1–3 in Table 3).
Enhancer activity was detected for the ZPBP2 promoter
region (region 2) in Jeg3 and MG63 cells, for region 1 in
Jeg3 cells; for the ORMDL3 promoter (region 6) and 3
regions in MG63 cells; for the ORMDL3 promoter (region 7)
in all cell lines except Jurkat cells (Table 3). SigniWcant alle-
lic eVects were observed for regions 2 and 3 (Table 3).
Collectively, our data demonstrate that the common SNP
rs4795397 is a regulatory polymorphism that aVects pro-
moter activity, nucleosome positioning and is part of an
enhancer region.
Table 2 Enrichment of the 
rs4795397 region chromatin 
with transcription factors in 
LCLs
ChIP Enrichment Allelic eVect tested 
by Sanger sequencing 
in heterozygous LCLs 
(number of LCLs tested)
All genotypes 
(number of LCLs 
tested)
Homozygous 
HapA (number 
of LCLs tested)
Homozygous 
HapB (number 
of LCLs tested)
NFkB 2.06 § 0.60 (8) 2.42 § 0.73 (3) 1.57 § 0.14 (3) Absent (2)
CTCF 1.06 § 0.46 (8) 1.11 § 0.51 (4) 1.01 § 0.49 (4) nt
YY1 3.36 § 1.57 (5) 3.58 § 2.16 (3) 3.03 (2) nt
EP300 2.63 § 0.91 (4) 2.86 (2) 2.39 (2) nt
R N A  P O L  I I 6 . 7 5  ( 2 ) n tn tA b s e n t  ( 2 )
Histone H3K9Ac 57.41 § 20.95 (4) 50.44 (2) 64.27 (2) nt
Histone H3K27me3 1.98 § 0.20 (4) 1.92 (2) 2.04 (2) nt
Standard deviation is given if 
three of more LCLs were tested
nt not tested1166 Hum Genet (2012) 131:1161–1171
123
DNA methylation of promoter regions
Monoallelic expression of certain X-linked and imprinted
genes results from allelic diVerences in promoter methyla-
tion. To determine if promoter methylation had an eVect on
the expression of the 17q12-q21 genes in LCLs, methyla-
tion proWles of the annotated IKZF3,  ZPBP2,  GSDMB,
ORMDL3 and GSDMA promoters and Wrst exons were
determined (Fig. 2). The ORMDL3 and IKZF3 promoters
were unmethylated in all tested cell lines independent from
their genotypes (supplementary Figs. 2S, 3S). The anno-
tated  GSDMB promoter and exon 1 of isoform 2 were
highly methylated in all genotypes [11 LCLs were tested,
(supplementary Fig. 4S)] suggesting that transcription of
the major annotated isoform 2 of GSDMB was suppressed
in LCLs, which is in agreement with the exome sequencing
data (Fig. 2a). It is worth noting, however, that the haplo-
type HapA contains polymorphisms that abolish three out
of seven CG sites in the annotated GSDMB promoter.
Moreover, this region had slightly lower mean methylation
levels in LCLs that were homozygous for the HapA haplo-
type (n = 3; mean methylation level 79.7%) compared to
LCLs that were heterozygous (n = 4, mean methylation
level 95.7%) or homozygous for the HapB haplotype
(n = 4, mean methylation level 95.6%). For all 11 LCLs,
the methylation level of the GSDMB promoter and exon 1
was inversely correlated with RNA abundance (Pearson’s
correlation coeYcient r = ¡0.63,  =0 . 0 5 ) .
In contrast to ORMDL3 and GSDMB promoters, the
ZPBP2 promoter and exon 1 region showed highly variable
DNA methylation patterns both within and between cell lines
(Fig. 3a). Sixteen LCLs were tested. The ZPBP2 promoter
was highly methylated in cell lines homozygous for the
asthma-associated HapA haplotype (n = 5) and in heterozy-
gous cell lines (n = 6), but had lower methylation levels in
cell lines that were homozygous for the non-asthma associ-
ated HapB haplotype (n = 5). To determine if ZPBP2 meth-
ylation depended upon the parental origin of the allele, we
compared the methylation proWles of maternal and paternal
alleles in two LCL DNA samples, NA10838 and NA12878.
No signiWcant parental origin eVect was detected.
Comparison of ZPBP2 promoter and exon 1 methylation
and expression levels showed a strong inverse correlation
between methylation of exon 1 and ZPBP2 RNA levels
(Pearson’s correlation coeYcient  R = ¡0.88,   =0 . 0 5 )
(Fig. 3b). Hence, methylation levels of ZPBP2 exon 1 inXu-
ence ZPBP2 RNA levels and explain the apparent contradic-
tion between high in vitro activity and FAIRE enrichment
of the ZPBP2 promoter region and lower expression of
ZPBP2 in LCLs that carry the asthma-associated haplotype
HapA.
GSDMA is not expressed in LCLs (Fig. 2a), therefore
LCLs are not the appropriate model for testing genetic
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cis-regulatory eVects on its expression. However, increased
expression of GSDMA was found in cord blood lymphocytes
of individuals that carry the asthma-associated 17q12-q21
alleles (Lluis et al. 2011), suggesting that GSDMA cannot
be excluded from the list of putative asthma genes. Hence,
to obtain a complete picture of promoter methylation in the
17q12-q21 region we determined the methylation proWle of
the GSDMA promoter region in LCLs and found inter-
individual variation among LCLs with respect to methylation
levels (supplementary Fig. 5S).
We also tested the methylation proWle of the rs4795397
region for allelic eVects and found that it was unmethylated
independent of genotype (supplementary Fig. 6S).
Overall, the methylation proWles of promoter regions
show a good correlation with the expression levels of
respective genes, i.e. highly expressed transcripts such as
IKZF3 and ORMDL3 have completely unmethylated pro-
moters, while genes with even partial promoter methylation
show a considerably reduced transcriptional activity.
Discussion
The asthma-associated chromosomal region 17q12-q21
harbors several genes that show allelic diVerences in
expression in LCL. Our data suggest that allelic variation in
expression arises from the interaction between several
genetic polymorphisms and epigenetic factors. We have
previously reported the eVect of the common SNP
rs12936231 on CTCF binding and nucleosome occupancy
(Verlaan et al. 2009a). In the present study, we demonstrate
that another common SNP, rs4795397 that is part of the cis-
regulatory haplotype and is located within the promoter
region of the ZPBP2 is a putative functional polymorphism
that shows allele-speciWc nucleosome occupancy and in
vitro promoter activity. The rs4795397 region is enriched
with YY1 and co-activator protein EP300. YY1 and EP300
are known to form regulatory complexes that may repress
(Galvin and Shi 1997; Lee et al. 1995) or activate (Mokrani
et al. 2006, Baumeister et al. 2005) gene transcription in
response to diVerent stimuli including endoplasmic reticu-
lum stress and viral infection. The rs4795397 region is
enriched with the active histone mark H3K9Ac, but not the
repressive chromatin mark H3K27me3, an observation
which is consistent with the histone acetyltransferase activ-
ity of EP300 (Ogryzko et al. 1996). Overall, the ChIP
and FAIRE results indicate an active chromatin state at
the rs4795397 region. Furthermore, our data show that
although rs4795397 has a strong inXuence on promoter
activity in vitro, in LCLs, its eVect on ZPBP2 transcription
Fig. 2 Promoter methylation and gene expression patterns in the
17q12-q21 region. a Exome sequencing results for the region 17q12-
q21 in two LCLs (GM12891 and GM12892). b Summary of DNA
methylation results for the 17q12-21 region. Red rectangles below the
diagram reXect the relative RNA abundance for genes in the region1168 Hum Genet (2012) 131:1161–1171
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is masked by DNA methylation of exon 1 of the ZPBP2
gene. Moreover, DNA methylation levels of the ZPBP2
exon 1 seem to depend upon the cis-regulatory haplotype as
only LCLs that are homozygous for the HapB haplotype
have lower exon 1 methylation and higher ZPBP2 RNA
levels (Fig. 3).
In summary, our data show that most allele-speciWc reg-
ulatory eVects such as nucleosome occupancy, DNA meth-
ylation, and in vitro promoter and enhancer activity localize
in a 5.3-kb region overlapping with the ZPBP2 gene at least
31 kb away from the ORMDL3 gene that shows allelic
diVerences in expression [(Verlaan et al. 2009a) and this
work]. The sum of our data suggests that this region harbors a
strong enhancer. Our conclusions are also consistent with
the Chromatin State Segmentation by HMM mapping results
(http://genome.ucsc.edu/EncodeBroadHmm) (Ernst and
Kellis 2010; Ernst et al. 2010). It remains to be determined
if the ZPBP2 enhancer region exerts a long-range regula-
tory eVect that extends beyond the ZPBP2 gene and con-
tributes to the allele-speciWc diVerences in the expression of
ORMDL3 and other genes in the region (Verlaan et al.
2009a).
The functional SNP rs4795397 is located within the pro-
moter region of ZPBP2, a gene whose importance for fertil-
ization and male fertility has been demonstrated in both
mice and humans (Lin et al. 2007; Redgrove et al. 2011).
The rs4795397-A allele that boosts the ZPBP2 promoter
activity in vitro is also part of the asthma-associated haplo-
type HapA. The exon 1 of ZPBP2 is unmethylated in
human sperm (S. Berlivet and A. Naumova, unpublished)
and cannot block the allelic eVect of rs4795397 on gene
expression. Therefore, it is conceivable that spermatozoa from
male carriers of the asthma-associated rs4795397-A allele
have a higher supply of the ZPBP2 protein and potentially
Fig. 3 Variable DNA methylation of ZPBP2 exon 1 deWnes ZPBP2
expression levels. a Filled circles represent methylated cytosines, open
circles represent unmethylated cytosines in CG pairs. Each row repre-
sents the methylation pattern of a single clone, i.e. one allele. The CG
ID number is shown on the top of the panel and the ID of the cell line
is shown on the left. A total of 51 CG sites were analyzed. CGs 29-51
that are located within exon 1 of ZPBP2 and have greater variability in
DNA methylation are shown in the Wgure. b Negative correlation
between  ZPBP2 exon 1 methylation and ZPBP2 RNA abundance.
ZPBP2 expression was evaluated using real-time RT-PCR and normal-
ized to the 18S RNA levels as described in (Verlaan et al. 2009a)Hum Genet (2012) 131:1161–1171 1169
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an increased fertilization capacity. This may provide a
slight advantage at the population level and lead to an
increased transmission of the asthma-associated haplotype
from fathers to oVspring.
Our results provide an example where inter-individual
variation in DNA methylation acts as a modiWer of genetic
inXuences on gene expression and may interfere with
genetic mapping of cis-regulatory polymorphisms by atten-
uating the genetic eVect on transcription and thereby the
signiWcance of genetic association results as in the case of
the ZPBP2 gene. Based on our results, we speculate that
promoters and Wrst exons of genes that show genetic cis-
eVect on expression levels with genome-wide statistical
signiWcance are likely not methylated at all, or else may
have allele-speciWc methylation, where the low expressing
allele would have high promoter methylation and vice
versa.
DNA methylation of promoter and enhancer elements
varies with cell type and/or developmental stage (Eckhardt
et al. 2006; Ghosh et al. 2010). Therefore, cell-type speciWc
DNA methylation patterns have to be taken into account in
the search for candidate disease gene. Several lines of evi-
dence point to ORMDL3 as the best 17q21 candidate causal
gene for childhood asthma. Its expression levels show asso-
ciation with genotype in LCLs (MoVatt et al. 2007; Verlaan
et al. 2009a, b), T lymphocytes (Murphy et al. 2010) and
cord blood lymphocytes (Lluis et al. 2011). ORMDL3 is
also expressed in bronchial epithelial cells and its RNA lev-
els are slightly higher in asthmatic subjects compared to
controls, whereas GSDMB and ZPBP2 are practically not
expressed (Bochkov et al. 2010). Whether or not ORMDL3
is the causal gene responsible for predisposition to asthma
remains to be addressed using other approaches. It is
important to note, however, that while the current experi-
mental evidence excludes IKZF3 (IKZF3 is not aVected by
the haplotype eVect in LCLs or T lymphocytes), it is not
suYcient for ruling out ZPBP2, GSDMB or GSDMA as
contributors to predisposition to asthma. Allelic transcrip-
tion of GSDMB in LCLs and T lymphocytes has been pre-
viously demonstrated (Verlaan et al. 2009a,  b; Murphy
et al. 2010). As for ZPBP2 and GSDMA, it is possible that
in certain cell types their promoters may be unmethylated
and their transcription may also depend on the haplotype.
To exclude ZPBP2,  GSDMB and GSDMA and narrow
down the list of candidate genes for predisposition to
asthma expression studies in cell types that are relevant for
the etiology of asthma are necessary.
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